Outcome of follicular lymphoma grade 3: is anthracycline necessary as front-line therapy?
Open Access
- 1 July 2003
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 89 (1) , 36-42
- https://doi.org/10.1038/sj.bjc.6601006
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell LymphomaNew England Journal of Medicine, 2002
- Follicular large cell lymphoma: Long-term follow-up of 62 patients treated between 1973–1981Annals of Oncology, 2000
- Follicular large cell lymphoma: an aggressive lymphoma that often presents with favorable prognostic features.1999
- Limited Stage I and II Follicular Non-Hodgkin's Lymphoma: The Nebraska Lymphoma Study Group ExperienceLeukemia & Lymphoma, 1999
- New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project.Journal of Clinical Oncology, 1998
- Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.Journal of Clinical Oncology, 1998
- FOLLICULAR LYMPHOMAS:Hematology/Oncology Clinics of North America, 1997
- A Predictive Model for Aggressive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Criteria for the cytologic subclassification of follicular lymphomas: A Proposed alternative methodHematological Oncology, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958